The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughes, D. A.
Right arrow Articles by Gordon, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughes, D. A.
Right arrow Articles by Gordon, S.
The Journal of Immunology, 1998, 160: 4543-4552.
Copyright © 1998 by The American Association of Immunologists

Expression and Function of the Type 3 Complement Receptor in Tissues of the Developing Mouse1

Derralynn A. Hughes and Siamon Gordon2

Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Macrophage (M{phi}) expression of the leukocyte integrins has been implicated in their adhesion and migration in the adult. Little is known, however, of the expression or function of these molecules during development. This study defines the spatial and temporal sequences of expression of the type 3 complement receptor (CR3) in the developing mouse; establishes the functional efficacy of this molecule in spreading, adhesion, and phagocytosis; and investigates its role in inflammatory and constitutive migration. Expression of CR3 on monocytes occurred early compared to M{phi}-restricted glycoprotein F4/80, but expression on stellate tissue M{phi} appeared later than F4/80 and was transient. Expression of CR3 on resident tissue M{phi} is more widespread during development, being retained on only very specific M{phi} populations in the adult. Neutrophil polymorphs expressed CR3 from day 17 of gestation onward. The anti-CR3 mAb 5C6 was used to investigate the role of CR3 in adhesion, spreading, and phagocytosis by neonatal M{phi}. Neonatal macrophages were found to adhere, spread, and phagocytose by CR3-dependent mechanisms, and a CR3-independent system was implicated in the spreading of neonatal M{phi}. The role of CR3 in migration during development was then investigated. 5C6 had potent effects on the early stages of the migration of myelomonocytic cells to an inflammatory stimulus in vivo. Despite efficient transplacental transfer of the Ab from pregnant mother to fetus, the process by which monocytes generate populations of resident tissue M{phi} was undisrupted, indicating the existence of CR3-independent mechanisms of monocyte migration during development.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cell surface receptors facilitate important interactions between macrophage (M{phi})3 and their environment during murine development (1). Cellular and soluble signals coordinate the differentiation of stem cells into monocytes, which enter the blood to form a pool of migration competent cells and subsequently enter every organ in the body to form heterogeneous populations of tissue M{phi} (2, 3, 4). The differentiation Ag F4/80 is first expressed in the 10-day-old embryo on monocytes and some stellate M{phi} in the yolk sac, and then on M{phi} populations in the liver (day 11), spleen (day 12), and bone marrow (day 17). Monocyte infiltration and local proliferation also result in the appearance of abundant F4/80+ M{phi} in mesenchymal organs during this period (5). However, it is not clear whether this temporal progression of monocyte appearance in various organs represents serial migration or whether each organ is seeded from common sources of stem cells. Furthermore, while previous studies have used mAb F4/80, which recognizes a M{phi}-restricted plasma membrane glycoprotein (6), to describe the distribution of M{phi} during development (5), the signals and receptors involved in the entry, migration, and exit of monocytes within developing tissues are not known.

In the adult mouse, constitutive migration of monocytes from the bone marrow maintains most resident tissue M{phi} populations (7) and continues alongside inflammatory and immunologically driven recruitment processes in which a family of structurally and functionally related surface glycoproteins, the leukocyte ß2 integrins (LFA-1, CR3, and p150,95) (8), have been implicated (9, 10, 11). Each of these molecules consists of an antigenically distinct {alpha}-chain (150–190 kDa) noncovalently associated with a ß-chain (95 kDa) as an {alpha}1ß2 dimer (reviewed in 12 . Congenital inability to express the ß2 chain results in an impairment of surface expression of all three heterodimers, severe defects in leukocyte accumulation in vivo and adherence in vitro, and an increase in life-threatening infections (13). However, the role of these molecules in the constitutive or inflammatory migration of monocytes during development is unknown.

Similarly, while the distribution of leukocyte integrins in the adult is well documented (14, 15), little is known of their expression during ontogeny. In the adult, CR3 is expressed on monocytes, neutrophilic polymorphonuclear leukocytes (PMN), and NK cells in blood and hemopoietic tissues, but not on populations of stellate tissue M{phi}, except microglia in the brain, marginal zone M{phi} in the spleen, and M{phi} in the subcapsular sinus of the lymph node (16). This suggests that CR3 expression is widely down-regulated as a consequence of constitutive entry of monocytes into tissues and differentiation into resident M{phi} such as Kupffer cells and implies a possible role for CR3 in development. In contrast, high levels of CR3 expression are retained on M{phi} that have been recruited to tissues in response to inflammatory signals.

The aim of this study, therefore, was to analyze the spatial and temporal sequences of CR3 expression in fetal and neonatal tissues as a first step to define its role in constitutive and inflammatory monocyte recruitment during development. Subsequently, mAb 5C6, which blocks CR3-dependent adhesion of M{phi} to bacteriologic plastic (BP) and has potent effects on some forms of myelomonocytic migration in vivo (17, 18, 19, 20), also provided a useful tool to determine the ability of CR3 on isolated neonatal M{phi} to mediate adhesion, spreading, and phagocytosis. Having then established the efficacy of neonatal CR3 in vitro, its role in the processes of constitutive and inflammatory myelomonocytic migration during development was also investigated.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals

Embryos and newborn mice (Pathology Oxford (PO)) were bred at the Sir William Dunn School of Pathology (Oxford, U.K.) and maintained under conventional laboratory conditions with free access to food and water. Females were inspected daily for the presence of a vaginal plug, which was designated day 0 of pregnancy. The day of birth (usually day 19 of pregnancy) was designated day 0 of neonatal life.

Antibodies

The following rat mAbs were used as hybridoma supernatants for immunohistochemistry. F4/80 (21) recognizes a 160-kDa Ag of unknown function. M1/70 (22) and 5C6 (18) were used in combination at a final dilution of 1/10 in PBS to recognize the CR3. Biotinylated rabbit anti-rat IgG were obtained from Vector Laboratories (Peterborough, U.K.). Polyclonal Abs recognizing F4/80 and sialoadhesin were prepared in our laboratory by Drs. P. Dri and P. Crocker and were routinely used at a dilution of 1/500 for immunohistochemistry.

Immunocytochemical techniques

Fixation and sectioning of murine organs. Embryos from day 8 to birth and neonatal animals up to 2 wk after birth were examined. Visceral yolk sac, liver, spleen, bone marrow, thymus, lung, kidney, and gut were dissected from conceptuses as they became readily identifiable. Organs were washed in PBS before freezing in OCT embedding medium (Miles, Elkhart, IN) cooled in isopentane (BDH-Merck, Poole, U.K.) over liquid nitrogen. Frozen sections were cut on a cryostat (Leica, Wetzlar, Germany) at 5 µm, air-dried for 1 h, and frozen at -20°C until further use. Fresh organs were fixed for 10 min in 2% paraformaldehyde in HEPES-buffered isotonic saline before staining; 2 mM calcium chloride was added to the fixative to maintain the structural conformation of the integrin.

Ag detection. Fixed sections were washed in PBS containing 0.1% (v/v) Triton X-100 (BDH-Merck) and treated with 2% normal rabbit serum for 30 min. Sections were incubated for 90 min in hybridoma supernatant, PBS, or isotype-matched control mAb. Endogenous peroxidase activity was inactivated by incubation of sections with 10-2 M glucose, 10-3 M NaN3, and 40 U glucose oxidase in 100 ml 0.1 M phosphate buffer for 15 min at 37°C (23). Affinity-purified, mouse-adsorbed, biotinylated second Ab (Vector) was used at 1% for 45 min, and avidin-biotin-peroxidase complex (ABC elite, Vector) (24) was used according to the supplier’s recommendation. The presence of Ag was revealed by incubation with 0.5 mg/ml 3,3'-diaminobenzidine HCl (Polysciences, Northampton, U.K.) and 0.024% H2O2 in 10 mM imidazole in PBS, pH 7.4.

Double labeling. To detect a second Ag, polyclonal Abs were incubated on sections for 90 min followed by 1% alkaline phosphatase-conjugated goat anti-rabbit second Ab for 60 min (Vector). The Ag was revealed by incubation with a 5-bromo-4-chloro-3-indolylphosphate/nitro blue tetrazolium alkaline phosphatase substrate kit (Vector), and sections were counterstained in cresyl fast violet acetate (BDH-Merck) and mounted in DPX (BDH-Merck). Sections in which primary Ab, secondary Ab, or avidin-biotin-peroxidase complex reagent were omitted and sections treated with irrelevant control Abs showed no staining.

In vivo detection of Ags. Pregnant mice were injected i.v. with 0.5 mg of 5C6 mAb or isotype-matched control mAb, 1C5 (which does not react with the surface of murine leukocytes) (25), on days 14 and 17 of pregnancy. Newborn PO mice were injected i.p. with 0.05 mg of purified rat mAb. Offspring of the pregnant mice or the newborn mice injected directly were subsequently fixed by perfusion with 2% periodate-lysine-paraformaldehyde solution (PLP) (26). After postfixing in the same solution for 4 h, tissues were impregnated with 20% sucrose in 0.1 M phosphate overnight before freezing and sectioning, as described. No further fixation of these sections was required. Affinity-purified, mouse-adsorbed, biotinylated anti-rat Ab (Vector) was used to locate injected rat Abs, and polyclonal rabbit anti F4/80 antiserum was used to define the distribution of F4/80+ monocytes or M{phi} in these sections.

Photography. Representative black and white photographs were taken using a blue filter (Wratten Gelatin Filter no. 47, Kodak, Rochester, NY) that intensifies the brown precipitate. Color photographs were taken using a 15-cc magenta filter.

Neonatal peritoneal M{phi}. Resident peritoneal M{phi} (RPM) were obtained from the cavities of 3-day-old PO mice by lavage with 1 ml of PBS. Recruited cells were similarly harvested from 3-day-old PO mice that had been injected i.p. with 25 µl of Brewer’s complete thioglycolate broth on the day of birth.

Adhesion to artificial substrata (18). Cells to be assayed for adhesion were resuspended in RPMI 1640 with 10% FBS and plated at a density of 3 x 105 M{phi}/well in flat-bottom BP or tissue culture plastic (TCP) 96-well plates (Flow Laboratories (Rickmansworth, U.K.) and Nunc/Life Technologies (Paisley, U.K.)). mAb (5 µg/ml) alone or in combination with divalent cation chelator (5 mM EDTA) were added to test wells and incubated for 30 min at 4°C. After incubation for 90 min at 37°C, plates were washed three times in PBS, and adherent cells were fixed in methanol and stained with 40% Giemsa solution for 1 h. Plates were washed in tap water, and the retained dye was solubilized in methanol and quantified by measuring absorbance at 450 nm in an automatic plate reader (Anthos III, Denley Instruments, Billinghurst, U.K.). In some assays cell viability was assessed at each stage using trypan blue dye exclusion (Sigma, Poole, U.K.).

Spreading assays

Cells were resuspended in RPMI 1640 plus 10% FBS and plated at a density of 105 M{phi}/chamber in multichamber slides. mAb (2 µg/ml 5C6 or control 1C5) or chelator (5 mM EDTA) was added to test chambers and retained throughout the experiment. Slides were washed in PBS, and adherent cells were fixed in 0.25% glutaraldehyde at 30 min or 1, 3, 6, 10.5, or 24 h. The number of cells with a spread morphology was assessed using phase contrast microscopy and expressed as a percentage of the total adherent cells.

Phagocytosis of opsonized red cells

Sheep erythrocytes (Becton Dickinson, Oxford, U.K.; stored in Alsever’s solution at 4°C until used) were incubated with 30% mouse IgM anti-sheep erythrocyte in PBS (Nordic Immunologic Laboratories, Tilburg, The Netherlands) for 45 min at 4°C, followed by fresh mouse serum for 30 min at 37°C to fix iC3b. Opsonized sheep erythrocytes (EAiC3b) were used at a 5% (v/v) suspension for 60 min to assay for rosetting at 4°C or phagocytosis at 37°C (27, 28). Binding was quantified by counting the number of erythrocytes attached to 100 M{phi}. Noninternalized erythrocytes were lysed in 0.147 M NH4Cl before counting the number of erythrocytes ingested per 100 M{phi}.

LPS-induced myelomonocytic recruitment

Newborn PO mice were injected intradermally with 10 µl of PBS or LPS (0.2 µg) containing 1% Monestral blue to mark the site of the lesion and at the same time i.p. with 0.05 mg of purified 5C6 or isotype-matched control mAb (1C5). Animals were perfusion fixed with PLP at 1, 4, 8, 10. 5, 24, and 56 h after injection and processed as described above to reveal injected mAb and F4/80 on recruited cells.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Expression of the leukocyte integrin, CR3, during murine development

To establish a basis for manipulation of myelomonocytic cell migration during the ontogeny of the mononuclear phagocyte system, the expression of CR3 on monocytes, M{phi}, and PMN during murine development was investigated. Tissue samples were taken throughout fetal and neonatal life and stained using a combination of two mAbs, M1/70 and 5C6, which show differential sensitivity to digestion of the cell surface with pronase and are therefore believed to recognize different epitopes of CR3 (18). No staining was observed with the irrelevant isotype-matched mAbs CAMPATH-1G or 1C5. Organs from at least two mice from each of three independent litters were examined at each developmental stage, and in each case a comparison was made with consecutive sections stained with the F4/80 polyclonal Ab.

Lymphohemopoietic organs

Liver (Fig. 1Go). The liver primordium develops relatively earlier in the mouse than in man and is visible at only 9 days of gestation, when it is composed of broad hepatic cords separated by large sinusoids containing nucleated erythroblasts (Eb). CR3+ monocytes were found in the fetal liver of whole embryos from this time onward, whereas F4/80+ was only detected on monocytes from day 10 of gestation (day 10e; not shown). The density of CR3+ monocytes in liver increased as hemopoiesis progressed from day 11e (Fig. 1Goa) and by day 13e, when the liver is well developed, labeled monocytes could be seen in clusters around liver sinusoids (Fig. 1Gob). Hemopoietic foci were found intermingled within the hepatic cords, but unlike the stellate M{phi} detected by F4/80, CR3+ monocytes were not associated with developing Eb. The F4/80+ stellate M{phi} first exhibited CR3 expression on day 15 (Fig. 1Goc). By day 17e, CR3+ PMN were apparent and located in clusters of erythroid and myeloid cells around a CR3+ stromal M{phi} (Fig. 1God). CR3+ PMN and monocytes increased in number until shortly after birth (Fig. 1Go, e and f) and continued to be distributed unevenly throughout the liver, with high numbers of cells adjacent to the sinusoids. CR3 staining of stellate M{phi} was maximal around 8 days after birth (Fig. 1Gog) even though at this stage the M{phi} were no longer associated with remaining erythroid cells. Hemopoietic clusters containing CR3+ monocytes were rare by this stage, and mature M{phi} accounted for most of the CR3 staining. After birth, declining hemopoietic activity in the liver was associated with a decreased number of CR3-staining monocytes and PMN, while CR3 staining of mature M{phi} progressively decreased in intensity. In the adult, CR3 expression on spindle-shaped sinus-lining M{phi} (Kupffer cells) was much reduced or absent (Fig. 1Goh), in contrast to F4/80, which is highly expressed on mature Kupffer cells in the liver (not shown).



View larger version (112K):
[in this window]
[in a new window]
 
FIGURE 1. CR3 is expressed on hepatic monocytes and stellate M{phi} throughout murine development. a, Day 11 fetal liver: monocytes (arrows) are scattered among endodermal cells. b, Day 13 fetal liver: the number of CR3+ monocytes has increased and are located around the margins of the liver sinuses (s). c, Day 15 fetal liver: hemopoietic activity has increased and CR3 is now expressed at low levels on stellate M{phi} as well as on clustered monocytes. d, Day 17 fetal liver: CR3+ stellate M{phi} are associated with clusters of erythroid and CR3+ myeloid cells (both monocytes and PMN; c). e, Day 1 newborn liver: hemopoietic activity continues, and CR3+ M{phi} plasma membrane processes are still associated with hemopoietic cell clusters. f, Day 3 newborn liver: hemopoietic activity is now much reduced and CR3+ plasma membrane processes of the immature Kupffer cells (Kc) are only occasionally in contact with hemopoietic cells. g, Day 8 newborn liver: there are many highly membranous CR3+ Kc. No hemopoietic clusters. h, Adult liver: CR3 is expressed on spindle shaped sinus-lining M{phi}. Membrane staining of the cells is much reduced compared with that in the neonate. Bar = 50 µm.

 
Spleen (Fig. 2Go). By 11 days of gestation, the epithelial lining of the dorsal mesentery of the stomach is thickened and represents the anlage of the spleen. CR3+ monocytes first appeared among the cells of this rudimentary spleen on day 12e (Fig. 2Go, a and b), at the same time as F4/80+ expression was first detected on splenic monocytes. Ramified F4/80+ M{phi} appear on day 15e and are surrounded by developing red cells, but at this stage these cells do not express CR3 (Fig. 2Goc). From day 16e (Fig. 2God) the splenic architecture becomes more complex, with distinct arteries and veins and regions destined to become lymphoid areas, containing none of the monocytes or numerous CR3+ granulocytic cells that are then apparent in the developing red pulp (Fig. 2Goe). CR3+ monocytes and PMN continue to be detected in the red pulp immediately after birth and during adult life (Fig. 2Go, f and g). In contrast, CR3+ stellate M{phi} were most evident in the expanding marginal zone of the white pulp 1 wk after birth (Fig. 2Goh), and in the adult could be detected both in the marginal zone and occasionally around the central arteriole in the white pulp (Fig. 2Goi). The network of stromal M{phi} expressing F4/80 in the red pulp never expressed CR3.



View larger version (114K):
[in this window]
[in a new window]
 
FIGURE 2. Expression of CR3+ cells in the developing spleen occurs before the onset of local hemopoiesis. a, Day 12 fetal spleen: occasional CR3+ monocytes appear in the mesenchymal mass (arrow). b, Day 13 fetal spleen: CR3+ monocytes are distributed throughout the spleen. c, Day 15 fetal spleen is now an active site of hemopoiesis. The tissue is homogeneous in architecture and contains many CR3+ monocytes. d and e, Day 16 and 18 fetal spleen: some areas destined to become white pulp (w) are free of CR3+ cells. f, Day 1 newborn spleen: small areas of white pulp (wp) are already distinct; CR3+ monocytes, PMN, and M{phi} are present only in the red pulp. g, Day 4 newborn spleen: hemopoiesis is reduced, but continues throughout adult life. h, Day 8 newborn spleen: the spleen now resembles that of a normal adult. i, Adult spleen: stellate CR3+ marginal zone M{phi} (mz) delineate the white pulp (wp). The red pulp (rp) contains few CR3+ mature M{phi} but many monocytes and PMN. Bar = 50 µm.

 
Yolk sac. CR3 was detected on stellate M{phi} and monocytes within and along vessels of the vitelline yolk sac from the ninth day of gestation (day 9e; Fig. 3Goa), which is 1 day earlier than F4/80 expression has been observed on cells seen mainly in the yolk sac mesoderm; CR3 is also expressed on more stellate M{phi} within vessels than F4/80. The density of CR3 staining peaked on day 10e, when nucleated Eb were also seen within the blood spaces. At no stage were M{phi} associated with clusters of Eb.



View larger version (108K):
[in this window]
[in a new window]
 
FIGURE 3. CR3+ myelomonocytic cells are widely distributed in other developing organs. a, Day 9 yolk sac: both stellate M{phi} (sm) and monocytes (mo) are evident throughout the yolk sac. b, Day 17 fetal bone marrow: monocytes and PMN are visible in clusters (c) around stromal M{phi} (s). c, Day 14 fetal gut: CR3+ M{phi} lie just beneath the serosa of the gut but no staining is seen within the primitive villi (arrow). d, Day 18 fetal gut: CR3+ M{phi} are stained within the lamina propria and villi. e, Day 14 fetal lung. There are many CR3+ cells within the mesenchyme of the developing lung. f, Day 18 fetal lung. CR3+ cells are now within the loose connective tissues of the lung. g andh, Day 17 fetal and day 1 newborn thymus: a low frequency of CR3+ monocytes is found in the cortical region (c) of the developing thymus. Monocytes are found only in the vessels of the corticomedullary junction shortly before and after birth. Little staining is seen in the medulla (m). Bar = 50 µm.

 
Bone marrow. Hemopoietic stem cells and F4/80+ M{phi} invade the cartilaginous rudiment of bone on day 16e, resulting in the formation of the marrow cavity. CR3+ monocytes and PMN were evident within the stroma of the bone marrow from day 17e, when hemopoietic activity is initiated (Fig. 3Gob). Clusters of erythroid and CR3+ myeloid cells surround central F4/80+ M{phi} during development and in the adult mouse, but CR3 staining was only observed on the stromal M{phi} of the bone marrow from day 17e until shortly after birth and, unlike F4/80, was absent from these M{phi} in the adult as previously reported (29).

Nonhemopoietic tissues

F4/80+ and CR3+ monocytes were seen throughout the undifferentiated tissue within which organs develop. As organogenesis proceeds, F4/80+ M{phi} persist to become components of loose connective tissue of differentiated organs, whereas CR3 expression is variable depending on the organ.

Gut. CR3 was first detected on spindle-shaped M{phi} around the capsule of the gut on day 11e. One day later, when the lumen became visible, CR3+ M{phi} were still confined to the capsule, whereas F4/80+ M{phi} appeared in the lamina propria at this stage. From day 13e CR3+ monocytes appeared in the lamina propria circumferential to the developing villi, and on day 15 mature M{phi} were visible within the villi. The pattern of moderate CR3 expression on the stellate M{phi} within the villi and strong expression on monocytes of the lamina propria continued throughout development and in the adult (Fig. 3Go, c and d).

Lung. The lung anlage develops on day 9e as rudiments of larynx-trachea-bronchi. CR3+ M{phi}, with extensive processes, were evident around the outer margins of the mesenchyme of the developing lung from day 11e, at the same stage that F4/80+ cells were observed randomly distributed within the mesenchyme. By day 13 the lungs were clearly subdivided into lobes, and by day 14 the disappearance of mesenchyme from the lung was accompanied by the formation of airways and vessels with which some CR3+ monocytes and more spindle-shaped M{phi} were associated (Fig. 3Goe). CR3+ cells, often in pairs, and F4/80+ M{phi} were distributed throughout the intraalveolar septa of the lung from just before birth (Fig. 3Gof), whereas the alveolar M{phi} populations of the adult failed to express CR3 or F4/80.

M{phi} of the kidney failed to express CR3 at any point during development, whereas F4/80 was expressed on M{phi} between the tubules from day 12e.

Thymus. The thymus becomes visible as epithelial lobes surrounded by a thin outer capsule of mesenchyme at 13 days of gestation. Flattened F4/80+ cells can be seen in the thymus from this time. As the organ grows, the F4/80+ M{phi} increase in number and become more stellate, the majority of M{phi} were found in the cortical regions among developing thymocytes. By contrast, CR3+ monocytes could only be detected in the vascularized corticomedullary region of the thymus from day 16e onward when the thymus increases strikingly in volume and the flattened F4/80+ M{phi} do not express detectable levels of CR3 at any point during development or in the adult (Fig. 3Go, g and h).

Peritoneal cells

Resident and elicited neonatal peritoneal M{phi} were immunoreactive for CR3 (not shown).

The immunohistochemistry outlined above established that CR3 was expressed on monocytes and tissue M{phi} during development, but was gradually lost after birth from mature tissue M{phi} in many regions. The pattern of CR3 expression differed from that of F4/80 both spatially and temporally (summarized in Table IGo). CR3 was only retained on the marginal zone M{phi} of the spleen and the subcapsular M{phi} of the lymph nodes (not shown), which may be involved in trafficking of leukocytes into these organs in the adult. This was suggestive of a specific role for CR3 during the developmental period and was consistent with a possible role for CR3 in the adhesion or migration of monocytes into and within organs before they differentiate into resident tissue M{phi}. It was impossible to obtain neonatal peripheral blood monocytes in sufficient numbers to assess their use of CR3 in vitro; however, in the adult RPM have been successfully used as surrogate monocytes in adoptive transfer assays of migration (25). Isolated neonatal peritoneal M{phi} were therefore used to establish the functional competence of the CR3 expressed during murine development. The spreading, adhesion, and phagocytosis of neonatal peritoneal M{phi} were assessed at a stage when there was still significant expression of CR3 on the stromal M{phi} of spleen and liver.


View this table:
[in this window]
[in a new window]
 
Table I. Expression of F4/80 and CR3 during murine development

 
CR3-dependent adhesion of neonatal M{phi}

mAb 5C6 was initially selected for its ability to inhibit the adhesion of adult M{phi} to BP by blocking the interaction between CR3 and an undefined component of FBS that coats the plastic surface (18). This interaction is also inhibited by EDTA, since the receptor function of integrins depends on the presence of divalent cations (30, 31). In this study, short term adhesion assays to BP were performed with neonatal and adult peritoneal cells lavaged from the resting peritoneal cavity or after its stimulation 3 days previously with thioglycolate broth. The comparative adhesion qualities of the cells and the effects of chelation of divalent cations or preincubation of the cells with mAb 5C6 are shown in Figure 4Go, A and B. The adhesion of neonatal peritoneal M{phi} to BP, like that of adult M{phi}, was divalent cation dependent and almost completely inhibited by 5C6. The CR3 of neonatal cells is therefore functional in adhesion to BP. However, in contrast to the adult where thioglycolate-elicited peritoneal M{phi} (TPM) were more adherent than RPM, neonatal RPM adhered more readily to BP than neonatal TPM.



View larger version (31K):
[in this window]
[in a new window]
 
FIGURE 4. CR3-dependent adhesion and spreading of neonatal and adult peritoneal M{phi}. A and B, Adhesion of neonatal and adult M{phi} to bacteriologic plastic: preincubation of the cells with 5C6 mAb or chelation of divalent cations with EDTA inhibited the adhesion of both RPM and TPM to BP. Each data point represents eight replicate wells; results were confirmed in four independent experiments. C, Spreading of neonatal and adult peritoneal M{phi} on glass: 100% neonatal cells exhibited ramified morphology 21 h before the adult cells. Each data point represents three replicate wells; results were confirmed in three independent experiments. D, The spreading of neonatal and adult peritoneal M{phi} at 6 h was only partially inhibited by incubation with 5C6 mAb and was more fully inhibited by chelation of divalent cations using EDTA. Each data point represents three replicate wells; results were confirmed in three independent experiments.

 
Role of CR3 in the spreading of neonatal M{phi}

The interaction of M{phi} with more complex substrata such as serum coated glass or TCP can be described in the two phases: adhesion and spreading. 5C6 and EDTA, which inhibit M{phi} adhesion to BP, reduce the spreading of adult cells on glass and TCP, but fail to inhibit their adhesion. The kinetics of spreading of adult and neonatal peritoneal M{phi} on glass and its dependence on CR3 were assessed using a method previously described by Haynes et al. (32). Neonatal RPM spread more rapidly than adult RPM, such that 100% adherent neonatal cells had an extensively arborized morphology after only 3 h of incubation compared with 24 h for the adult RPM (Fig. 4GoC). Chelation of divalent cations inhibited the spreading of neonatal RPM on TCP (p < 0.01), whereas blocking CR3 with 5C6 mAb up to the 6 h point did not significantly inhibit their spreading on this surface. This indicates that the spreading of neonatal M{phi} involves divalent cation-dependent receptors other than CR3 or a conformation of CR3 not recognized by 5C6 (Fig. 4GoD). Since the proportion of adult M{phi} fully spread at the 6 h point was small (only 18.7%), the inhibitory effect of 5C6 and EDTA (20 and 58%) did not reach statistical significance. This time point was chosen to fall on the up-slope of spreading for both cell populations, thus potentially allowing both positive and negative effects of the Ab to be observed. The inhibitory effect of 5C6 and EDTA on adult cells at time points that allow full spreading has been well documented (18).

Role of CR3 in phagocytosis by neonatal M{phi}

In addition to adhesion and spreading, CR3 is known to mediate binding and ingestion of complement-opsonized particles by adult peritoneal M{phi} (33, 34). Figure 5Go summarizes the binding and phagocytosis of iC3b EAiC3b by neonatal and adult resident and recruited M{phi}. As previously documented (34), adult TPM were able to both bind and ingest EAiC3b, whereas RPM bound opsonized particles well, but ingested relatively few. Similarly, in the neonate both RPM and TPM bound EAiC3b, but ingestion of EAiC3b was greater by TPM than by RPM. In each case EAiC3b rosetting was inhibited by 5C6, indicating that the CR3 on both the resident and elicited neonatal peritoneal M{phi} is capable of binding iC3b and to some extent mediates ingestion of EAiC3b.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 5. CR3-dependent phagocytosis of iC3b-coated sheep erythrocytes by neonatal and adult peritoneal cells. Neonatal and adult RPM and day 3 TPM were plated in glass multichamber slides, and the binding and phagocytosis of EAiC3b was assessed. Each data point represents four replicate wells; results were confirmed in three independent experiments. A, The number of M{phi} with bound or internalized opsonized erythrocytes: neonatal TPM bound and internalized EAiC3b, whereas, like adult RPM, neonatal RPM bound cells more effectively than they internalized. B, The number of bound or internalized opsonized erythrocytes per M{phi}: neonatal M{phi} bound and internalized EAiC3b as effectively as comparable adult M{phi}.

 
LPS-induced myelomonocytic cell recruitment to neonatal skin

Since the epitope of CR3 recognized by 5C6 and implicated in adult myelomonocytic cell recruitment is present and active in adhesion and phagocytosis in the neonate, the ability of 5C6 to block inflammatory recruitment of cells in the neonate was examined. It is well documented that thioglycolate broth elicits a 10- to 20-fold influx of myelomonocytic cells into the adult peritoneal cavity 2 to 4 days after injection. Recruitment of myelomonocytic cells to the neonatal peritoneal cavity was examined by i.p. injection of sterile thioglycolate broth. However, in contrast to the adult, there was no detectable increase in the total number of cells within the peritoneal cavity over the 7 days after thioglycolate injection. Furthermore, the developmental, weight-related increase in the number of cells in the cavity was suppressed by thioglycolate (not shown). Since injection of control Ab, PBS, or 5C6 also prevented any developmental increase in cell number in the cavity, it is likely that any injection results in a sufficient inflammatory stimulus to induce the resident cells to leave or die within the cavity. For this reason an alternative model of inflammatory recruitment in neonatal mice was employed. It has been established that an acute inflammatory response in adult murine skin may be elicited by LPS. After intradermal injection, myelomonocytic recruitment into adult skin occurs within 2 h (35). This model was therefore adapted for the neonate.

One-day-old mice were injected i.p. with control Ab or 5C6 and intradermally with PBS or LPS, including monestral blue to mark the site of injection. Animals were fixed by PLP perfusion at various times, and the lesions were analyzed immunohistochemically.

One hour after injection, many CR3-labeled cells were found at the lesion, but few could be identified as monocytes using polyclonal F4/80. Cell recruitment was increased at 4 h; it was maximal 8 h after injection and consisted mainly of PMN (Fig. 6Go, a and b). By 24 h the total numbers of recruited cells had started to decline, and the infiltrate became predominantly monocytic in character (Fig. 6Go, c and d). The early, largely neutrophil, response was inhibited by the i.p. injection of 5C6 mAb. Figure 6Go, E and F, shows the absence of F4/80+ monocytes/M{phi} or CR3+ monocytes and PMN at the 24 h lesion. The later phase of monocytic recruitment appeared to be at least partially 5C6 resistant (Fig. 6Go, e–h), with both CR3- and F4/80-staining cells detectable in the vicinity of the LPS injection after 56 h. This result confirms the activity of CR3 in the inflammatory recruitment of neonatal PMN and monocytes and also suggests that, as in some models in the adult, other adhesion molecules are also involved.



View larger version (134K):
[in this window]
[in a new window]
 
FIGURE 6. CR3 is active in the initial stages of LPS-induced recruitment of myelomonocytic cells to the skin of neonatal mice. Newborn PO mice were injected intradermally with PBS or LPS containing Monestral blue to mark the site of the lesion and i.p. with purified 5C6 or isotype-matched control mAb (1C5). Animals were fixed by perfusion with PLP at various times after injection and stained to reveal CR3 on PMN and monocytes (a, c, e, and g; brown) and F4/80+ monocytes and M{phi} by means of a polyclonal Ab (b, d,f, and h: blue). Results were confirmed in three independent experiments. a and b, Skin 8 h after injection of LPS intradermally and control mAb i.p.: CR3+ PMN (p), but no F4/80-stained monocytes are visible at the site of the lesion marked with monestral blue (mb). c and d, Skin 24 h after injection of LPS intradermally and control mAb i.p.: CR3+ PMN (brown) and CR3+ F4/80+ monocytes (m, blue) are now both present at the site of LPS injection. e and f, Skin 24 h after injection of LPS intradermally and 5C6 mAb i.p.: the recruitment of both PMN and monocytes was blocked by 5C6. g andh, Skin 56 h after injection of LPS intradermally and 5C6 mAb i.p.: CR3+ F4/80+ monocytes (mo) are again visible at the site of LPS injection.

 
Role of CR3 in the constitutive migration of myelomonocytic cells during murine development

We next investigated whether the migration of cells expressing CR3 during prenatal development could be affected by 5C6. It was essential to know that the Ab could reach sites of expression if its effects on monocyte migration were to be assessed. Animals were injected with mAb i.v. on days 14 and 17 of pregnancy, and their offspring were fixed by perfusion 1 day after birth. 5C6 could be detected on M{phi} in the neonatal spleen (Fig. 7Goa), lamina propria of the gut (Fig. 7Gob), and Kupffer cells in the liver (Fig. 7Goc) and had therefore crossed the placenta. When Ab was injected i.p. into newborn mice, followed by PLP perfusion-fixation of the whole animal, 5C6 could be detected in the liver, thymus, and spleen 1, 4, 6, and 9 days after injection using a rat monoclonal detection system. In control animals that received PBS or isotype-matched control Ab, no in vivo labeling of cells could be detected (not shown). In animals injected with 5C6, PMN, monocytes, and some tissue M{phi} were strongly labeled in the developing hematolymphoid organs. Monocytes and marginal zone M{phi} were labeled in the spleen (Fig. 7God), monocytes were labeled in the corticomedullary region of the thymus (Fig. 7Goe), and Kupffer cells and monocytes were labeled in the liver (Fig. 7Gof). In the nonhematolymphoid organs of gut, brain, and skin, CR3+ cells were detected in architectural arrangements similar to those of conventionally stained specimens (not shown).



View larger version (122K):
[in this window]
[in a new window]
 
FIGURE 7. Transplacental transfer of 5C6 mAb labels CR3 on developing cells without disrupting their distribution. Pregnant (days 14 and 17 of gestation) and newborn mice (day 0) were injected i.v. with 5C6 mAb or its isotype-matched control 1C5 mAb. Tissues were subsequently fixed by perfusion, and the location of the injected mAb was determined using an anti-rat IgG detection system. The effect of the mAb on organ morphology and the distribution of other M{phi} Ags was assessed using rabbit polyclonal F4/80. a, Day 4 neonatal spleen after injection of 5C6 into the pregnant mother on days 14 and 17 of gestation: the 5C6 mAb has crossed the placenta to label monocytes and PMN in the developing spleen. b, Day 4 neonatal gut after injection of 5C6 to the pregnant mother on days 14 and 17 of gestation: the injected 5C6 stains monocytes and M{phi} in the lamina propria of the gut. c, Day 4 neonatal liver after injection of 5C6 to the pregnant mother on days 14 and 17 of gestation. The injected 5C6 mAb stains Kupffer cells (Kc). d, Newborn spleen, 1 day after injection: 5C6 labels monocytes and neutrophils within the red pulp (rp). Some labeled cells show mitotic figures. e, Newborn thymus, 1 day after injection: 5C6 marks myelomonocytic cells in the corticomedullary junction (cmj). f, Newborn liver, 1 day after injection of 5C6: Kc are stained by the injected Ab. g, Spleen from 5C6 injected animal stained with pF4/80: F4/80 detects stellate M{phi} within the red pulp (rp). No F4/80+ cells are found in the white pulp (wp). h, Liver from 5C6 injected animal, stained with pF4/80: F4/80 is readily detectable on Kc.

 
Rabbit polyclonal Abs against F4/80 and sialoadhesin were used to assess the effect of 5C6 on other M{phi} populations. (The detection system employed to locate the rabbit polyclonal Abs did not bind to the injected rat mAb.) No morphologic disruption or interference with the expression of F4/80 or sialoadhesin was observed over the extended time course over which the injected Ab could still be detected. In a number of Ab-treated animals there appeared to be an increased frequency of mitoses in the neonatal liver and spleen and an enhanced sinusoidal location of monocytes in the liver. Figure 7Gog shows pF4/80 staining in the spleen, and Figure 7Goh shows Kupffer cells in the liver 9 days after 5C6 administration, illustrating the morphologic integrity of the organs after Ab injection. This pattern of staining was identical with that detected in animals preinjected with control Ab and with that detected in native animals by Morris et al. (5). Therefore, while 5C6 exhibits the capacity to cross the placenta and be retained on the surface of myelomonocytic cells for several days after birth, such intervention does not interfere with the ability of the cells to find their organ-specific locations.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this study we have used a combination of mAbs that recognize different epitopes of CR3 (18, 36), a cell surface component involved in monocyte and neutrophil migration in the adult, to analyze its expression in the developing mouse. CR3+ monocytes and M{phi} were distinguished on account of their round or stellate morphology and frequent presence of phagocytic material in M{phi}. Neutrophils, which only became evident on day 16 or 17 of gestation, were small with a multilobed nucleus. Flow cytometric analysis has previously demonstrated large populations of CR3-positive myeloid cells in the fetal liver from day 11 of gestation, increasing up to birth and decreasing from the first to third weeks after birth (37). However, the study in question does not detect heterogeneity of expression within individual organs or distinguish between monocytes produced as a result of hemopoietic activity at the height of the CR3 expression and mature resident tissue M{phi}. Here we have compared the immunohistochemical distribution of CR3 during development with that of F4/80 (Table IGo) to analyze the expression of a known adhesion molecule on a population of developing cells identified by an independent marker. The expression of CR3 on monocytes within most developing organs preceded the appearance of F4/80+ monocytes or M{phi}, but the expression of CR3 on stellate tissue M{phi} appeared later than F4/80 and was transient, often being lost shortly after birth. The expression of CR3 on resident tissue M{phi} is therefore more widespread in the fetus and neonate than in the adult, except on very specific populations of adult M{phi} (Table IIGo). LFA-1 was detected on monocytes and M{phi} at the same stage as CR3 in most organs, but was retained during development and in the adult (not shown). This raises interesting questions about the regulation of CR3 expression during development, its function on monocytes and M{phi} in the embryo and neonate, and the significance of its down-regulation in the adult. It may be that its function is specific to an early window of monocyte/M{phi} life cycle and is lost as a consequence of monocyte differentiation within tissues. For example, CR3 expression on monocytes may be related to their capacity for migration and may no longer be required once a M{phi} is fixed within a tissue. CR3 expression on mature M{phi} in the lymph node and spleen occurs in areas of leukocyte entry into these organs (38); elimination of marginal zone M{phi} in the spleen reduces the accumulation of lymphocytes in this area (39), suggesting that these M{phi} have an active role in the trafficking of other cells. Furthermore, adoptively transferred RPM are first evident in the marginal zone of the spleen and subcapsular sinus of the lymph node (25), so that CR3 expressed in these regions might be related to newly extravasated cells that have not yet assumed a tissue phenotype.


View this table:
[in this window]
[in a new window]
 
Table II. Comparison of CR3 expression during development and in the adult

 
The CR3 of M{phi} isolated from the peritoneal cavities of neonatal mice was functional in in vitro assays of adhesion to BP and could be completely inhibited by mAb 5C6 or EDTA. However, the spreading of neonatal RPM, which was more rapid and extensive than that of adult RPM, could not be completely inhibited by 5C6. Integrins on leukocytes are normally inactive, in that they bind with only very low avidity to their ligands but can be triggered remotely by other membrane receptors or their own ligands to an activated conformation (40, 41). Further studies are required to establish whether the spreading of neonatal RPM is due to an activation-specific epitope of CR3 or to a different molecule. Enhanced spreading may be a reflection of recent extravasation from the blood to form the resident population or may be due to the presence of mediators within the newborn cavity, such as IFN-{gamma} (42) and TNF (43) or macrophage CSF (44), which are known to enhance the spreading of murine adult RPM in vitro.

To investigate the role of CR3 in inflammatory migration in neonates, LPS was introduced into the skin of neonatal mice. The initial phase of LPS-induced myelomonocytic recruitment in the neonate was blocked by mAb 5C6. However, despite the continued presence of 5C6-labeled M{phi} at the lesion, a later phase of myelomonocytic recruitment was still evident and therefore was independent of CR3. Analogous studies in the adult indicate that T cell-dependent inflammation induced by specific antigenic challenge in sensitized mice is also biphasic and is inhibited by 5C6 only in its initial phase even though the Ab is present and functional for 4 or more days (20) and recruitment of cells to pulmonary granulomata following Calmette-Guérin bacillus infection or to hepatic sinusoids in murine malaria are mostly independent of CR3-mediated mechanisms (9). The present study shows that induced monocyte migration in the neonate also has CR3-dependent and -independent components.

Administration of 5C6 to pregnant or newborn mice resulted in labeling of the CR3 Ag in vivo and demonstrated that mAb 5C6 was able to cross the placenta. This is of interest since 5C6 is also able to cross the blood-brain barrier (45), whereupon it induces mitoses and apoptosis of microglia. Low levels of mitosis were also observed in neonatal spleens and thymi after injection of this Ab, indicating that ligation of CR3 in the periphery may also stimulate cell division, but further quantitative studies are needed to establish whether this was enhanced relative to the background in the present model. 5C6 failed to disrupt constitutive monocyte migration to nonhematolymphoid organs or to affect myelomonocytic cell distribution in hematolymphoid organs. The expression of other differentiation markers, including F4/80 and sialoadhesin, was unaffected by the administration of 5C6 at or before birth. A variety of Abs did not detect any significant disruption of M{phi} distribution in tissues by 5C6 up to 9 days after its original administration. This is in keeping with studies indicating that migration of fluorescently labeled M{phi} from the blood to normal tissue in the adult is CR3 independent (25) and that normal M{phi} populations are found in CR3-deficient human patients to the extent examined (13). The development of mice deficient in CR3 is also grossly normal; however, details of M{phi} distribution during the embryonic period of these animals have not been reported (46).

This study has demonstrated high levels of CR3 expression in hematolymphoid and nonhematolymphoid organs during development that coincide with high levels of hemopoiesis and decline after birth. Prominent expression during the developmental period is compatible with a role for CR3 in hemopoietic cell migration. CR3 expressed on isolated neonatal peritoneal M{phi} is able to mediate adhesion and phagocytosis, and it contributes to the initial phase of myeloid cell recruitment to an inflammatory stimulus in vivo. However, mAb 5C6 was unable to inhibit the largely monocytic, delayed phase of recruitment to LPS or the constitutive migration of monocytes during development. M{phi} migration in the normal developing animal is therefore largely independent of CR3, which may perform additional, undiscovered functions in tissue modelling and myelomonocytic cell ontogeny.


    Acknowledgments
 
We thank Mr. L. Turley for excellent technical support, and Mrs. E. Darley for expert assistance with immunohistochemistry.


    Footnotes
 
1 This work was supported by the United Kingdom Medical Research Council, the United Kingdom Arthritis and Rheumatism Council, and a Theodore Williams Scholarship from Oxford University (to D.A.H.). Back

2 Address correspondence and reprint requests to Dr. Siamon Gordon, Sir William Dunn School of Pathology, University of Oxford, South Parks Rd., Oxford, U.K. OX1 3RE. Back

3 Abbreviations used in this paper: M{phi}, macrophage; PMN, polymorphonuclear leukocyte; BP, bacteriologic plastic; PO, pathology Oxford; PLP, periodate-lysine-paraformaldehyde solution; RPM, resident peritoneal macrophages; TCP, tissue culture plastic; EAiC3b, opsonized sheep red cells; Eb, erythroblasts; TPM, thioglycolate-elicited peritoneal macrophages. Back

Received for publication April 9, 1997. Accepted for publication January 5, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Gordon, S., V. H. Perry, S. Rabinowitz, L.-P. Chung, H. Rosen. 1988. Plasma membrane receptors of the mononuclear phagocyte system. J. Cell Sci. 9(Suppl.):1.[Abstract/Free Full Text]
  2. Dexter, T. M.. 1982. Stromal cell associated haemopoiesis. J. Cell Physiol. 1(Suppl.):87.
  3. Gallagher, J. T., E. Spooncer, T. M. Dexter. 1983. Role of the cellular matrix in haemopoiesis. J. Cell Sci. 63:155.[Abstract]
  4. Haworth, C.. 1989. Multifunctional cytokines in haemopoiesis. Blood Rev. 3:263.[Medline]
  5. Morris, L., C. F. Graham, S. Gordon. 1991. Macrophages in haemopoietic and other tissues of the developing mouse detected by the monoclonal antibody F4/80. Development 112:517.[Abstract]
  6. McKnight, A. J., A. J. Macfarlane, P. Dri, L. Turley, A. C. Willis, S. Gordon. 1996. Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family. J. Biol. Chem. 271:486.[Abstract/Free Full Text]
  7. Van Furth, R., Z. A. Cohn. 1968. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128:415.[Abstract]
  8. Springer, T. A., D. Davignon, M. K. Ho, K. Kurzinger, E. Martz, F. Sanchez-Madrid. 1982. LFA-1 and Lyt-2,3 molecules associated with T lymphocyte-mediated killing; and MAC-1, and LFA-1 homologue associated with complement receptor function. Immunol. Rev. 68:171.[Medline]
  9. Rosen, H., S. Gordon. 1990. The role of the type 3 complement receptor in the induced recruitment of myelomonocytic cells to inflammatory sites in the mouse. Am. J. Respir. Cell Mol. Biol. 3:3.
  10. Keizer, G. D., A. A. Te Velde, R. Schwarting, C. G. Figdor, J. E. De Vries. 1987. Role of p150,95 in adhesion, migration, chemotaxis and phagocytosis of human monocytes. Eur. J. Immunol. 17:1317.[Medline]
  11. Nishikawa, K., Y.-J. Guo, M. Miyasaka, T. Tamatani, A. B. Collins, M.-S. Sy, R. T. McCluskey, G. Andres. 1993. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J. Exp. Med. 177:667.[Abstract/Free Full Text]
  12. Hynes, R. O.. 1992. Integrins: versatility, modulation, and signalling in cell adhesion. Cell 69:11.[Medline]
  13. Anderson, D. C., T. A. Springer. 1987. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1 and p150,95 glycoproteins. Annu. Rev. Med. 38:175.[Medline]
  14. Flotte, T. J., T. A. Springer, J. Thorbecke. 1983. Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. Am. J. Pathol. 11:112.
  15. Larson, R. S., T. A. Springer. 1990. Structure and function of leukocyte integrins. Immunol. Rev. 114:181.[Medline]
  16. Gordon, S., L. Lawson, S. Rabinowitz, P. R. Crocker, L. Morris, V. H. Perry. 1992. Antigen markers of macrophage differentiation in murine tissues. Curr. Top. Microbiol. Immunol. 181:1.[Medline]
  17. Hutchings, P., H. Rosen, L. O’Reilly, E. Simpson, S. Gordon, A. Cooke. 1990. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 348:639.[Medline]
  18. Rosen, H., S. Gordon. 1987. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J. Exp. Med. 166:1685.[Abstract/Free Full Text]
  19. Rosen, H., S. Gordon, R. J. North. 1989. Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. J. Exp. Med. 170:27.[Abstract/Free Full Text]
  20. Rosen, H., G. Milon, S. Gordon. 1989. Antibody to the murine type 3 complement receptor inhibits T lymphocyte-dependent recruitment of myelomonocytic cells in vivo. J. Exp. Med. 169:535.[Abstract/Free Full Text]
  21. Austyn, J. M., S. Gordon. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:805.[Medline]
  22. Springer, T., G. Galfre, G. S. Secher, C. Milstein. 1979. Mac 1: a macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol. 9:301.[Medline]
  23. Locksley, R. M., C. B. Wilson, S. J. Klebanoff. 1983. Increased respiratory burst in myeloperoxidase-deficient monocytes. Blood 62:902.[Abstract/Free Full Text]
  24. Hsu, S. M., L. Raine, H. Fanger. 1981. The use of avidin-biotin complex (ABC) in immunoperoxidase techniques; a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29:577.[Abstract]
  25. Rosen, H., S. Gordon. 1990. Adoptive transfer of fluorescent labelled cells shows that resident peritoneal macrophages are able to migrate into specialized lymphoid organs and inflammatory sites in the mouse. Eur. J. Immunol. 20:1251.[Medline]
  26. McLean, I. W., P. K. Nakane. 1974. Periodate-lysine-paraformaldehyde fixative: a new fixative for immunoelectron microscopy. J. Histochem. Cytochem. 22:1077.[Abstract]
  27. Ezekowitz, R. A. B., R. B. Sim, G. G. Macpherson, S. Gordo. 1985. Interaction of human monocytes, macrophages and polymorphonuclear leucocytes with zymosan in vitro. J. Clin. Invest. 76:2368.
  28. Micklem, K. J., R. B. Sim, E. Sim. 1984. Analysis of C3 receptor activity on human b lymphocytes and isolation of complement receptor type 2. Biochem. J. 224:75.[Medline]
  29. Crocker, P. R., S. Gordon. 1985. Isolation and characterization of resident stromal macrophages and hematopoietic cell clusters from mouse bone marrow. J. Exp. Med. 162:993.[Abstract/Free Full Text]
  30. Gailit, J., E. Ruoslahti. 1988. Regulation of the fibronectin receptor affinity by divalent cations. J. Biol. Chem. 263:12927.[Abstract/Free Full Text]
  31. Kirchofer, D., J. Grzesiak, M. D. Pierschbacher. 1991. Calcium as a potential physiologic regulator of integrin-mediated cell adhesion. J. Biol. Chem. 266:4471.[Abstract/Free Full Text]
  32. Haynes, D. R., M. W. Whitehouse, B. Vernon-Roberts. 1991. The effects of some anti-arthritic drugs on the shape and function of rodent macrophages. Int. J. Exp. Pathol. 72:9.[Medline]
  33. Griffin, F. M., C. Bianco, S. C. Silverstein. 1975. Characterisation of the macrophage receptor for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G. J. Exp. Med. 141:1269.[Abstract/Free Full Text]
  34. Bianco, C., F. Griffin, S. Silverstein. 1975. Studies of the macrophage complement receptor: alteration of the receptor function on macrophage activation. J. Exp. Med. 141:1278.[Abstract/Free Full Text]
  35. Andersson, P. B., V. H. Perry, S. Gordon. 1992. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48:169.[Medline]
  36. Beller, D. I., T. A. Springer, R. D. Schreiber. 1982. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J. Exp. Med. 156:1000.[Abstract/Free Full Text]
  37. Velardi, A., M. D. Cooper. 1984. An immunofluorescence analysis of the ontogeny of myeloid and B lineage cells in mouse haemopoietic tissues. J. Immunol. 133:672.[Abstract]
  38. van den Berg, T. K., J. J. Breve, J. G. Damoiseaux, E. A. Dopp, S. Kelm, P. R. Crocker, C. D. Dijkstra, G. Kraal. 1992. Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule. J. Exp. Med. 176:647.[Abstract/Free Full Text]
  39. Kraal, G., H. Rodrigues, K. Hoeben, N. Van Rooijen. 1989. Lymphocyte migration in the spleen: the effect of M{phi} elimination. Immunology 68:227.[Medline]
  40. Cabanas, C., N. Hogg. 1993. Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1. Proc. Natl. Acad. Sci. USA 90:5838.[Abstract/Free Full Text]
  41. Ginsberg, M. H., X. Du, E. F. Plow. 1992. Inside-out integrin signalling. Curr. Opin. Cell Biol. 4:766.[Medline]
  42. Schultz, R. M.. 1980. Macrophage activation by interferons. E. Pick, ed. Lymphokine Reports 113. Academic Press, New York.
  43. Beutler, B., U. Trackeno, I. Milsark, N. Krochin, A. Cerami. 1986. Effect of {gamma}-interferon on cachectin expression by mononuclear phagocytes: reversal of lps(d) (endotoxin resistance) phenotype. J. Exp. Med. 164:1791.[Abstract/Free Full Text]
  44. Boocock, C. A., G. E. Jones, E. R. Stanley, J. W. . 1989. Colony stimulating factor-1 induces rapid behavioural responses in the murine macrophage cell line BAC1.2F5. J. Cell Sci. 93:447.[Abstract/Free Full Text]
  45. Reid, D. M., V. H. Perry, P.-B. Andersson, S. Gordon. 1993. Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood brain barrier. Neuroscience 56:529.[Medline]
  46. Coxon, A., P. Rieu, F. J. Barkalow, S. Askari, A. H. Sharpe., U. H. von Adrian, M. A. Arnaout, T. N. Mayadas. 1996. A novel role for the ß2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 5:653.[Medline]



This article has been cited by other articles:


Home page
BloodHome page
J. Y. Bertrand, A. Jalil, M. Klaine, S. Jung, A. Cumano, and I. Godin
Three pathways to mature macrophages in the early mouse yolk sac
Blood, November 1, 2005; 106(9): 3004 - 3011.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. B. Geutskens, T. Otonkoski, M-A. Pulkkinen, H. A. Drexhage, and P. J. M. Leenen
Macrophages in the murine pancreas and their involvement in fetal endocrine development in vitro
J. Leukoc. Biol., October 1, 2005; 78(4): 845 - 852.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. H. Horwitz, J. P. Mizgerd, M. L. Scott, and C. M. Doerschuk
Mechanisms of granulocytosis in the absence of CD18
Blood, March 15, 2001; 97(6): 1578 - 1583.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Lichanska, C. M. Browne, G. W. Henkel, K. M. Murphy, M. C. Ostrowski, S. R. McKercher, R. A. Maki, and D. A. Hume
Differentiation of the Mononuclear Phagocyte System During Mouse Embryogenesis: The Role of Transcription Factor PU.1
Blood, July 1, 1999; 94(1): 127 - 138.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughes, D. A.
Right arrow Articles by Gordon, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughes, D. A.
Right arrow Articles by Gordon, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS